A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients: ACCeRT Study

Elaine S Rogers, Roderick D MacLeod, Joanna Stewart, Stephen Bird, Justin WL Keogh

    Research output: Contribution to journalArticlepeer-review

    27 Citations (Scopus)
    29 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients: ACCeRT Study'. Together they form a unique fingerprint.

    Medicine & Life Sciences